Person:
Rayón Valpuesta, Esperanza

Profile Picture

Email Address

person.page.identifierURI

https://academica-e.unavarra.es/handle/2454/49830

Birth Date

Job Title

Last Name

Rayón Valpuesta

First Name

Esperanza

person.page.departamento

Ciencias de la Salud

person.page.instituteName

ORCID

0000-0003-0335-2362

person.page.observainves

750906

person.page.upna

811188

Name

Filters

2021 - 20253
Reset filters

Settings

Search Results

Now showing 1 - 3 of 3
  • Thumbnail Image
    PublicationOpen Access
    The impact of COVID-19 on DTP3 vaccination coverage in Europe (2012-2023)
    (MDPI, 2025-12-24) Aguinaga Ontoso, Inés; Guillén Aguinaga, Sara; Guillén Aguinaga, Laura; Alas Brun, Rosa María; Guillén-Aguinaga, Miriam; Onambele, Luc; Aguinaga Ontoso, Enrique; Rayón Valpuesta, Esperanza; Guillén Grima, Francisco; Ciencias de la Salud; Osasun Zientziak
    Background: The COVID-19 pandemic disrupted routine child immunization efforts, threatening to reverse progress in controlling vaccine-preventable diseases. Materials and Methods: We analyzed the impact of COVID-19 on DTP3 vaccination in Europe by comparing trends before and after the pandemic using time series data from 2000 to 2023. Employing joinpoint regression, chi-square tests, and segmented regression analysis, we assessed DTP3 vaccination trends and coverage changes. Results: The findings revealed significant regional disparities across Europe. Statistical models indicated reductions in DTP3 coverage in countries such as Ireland, Sweden, and Switzerland, whereas Ukraine and San Marino showed improvements. Conclusions: There are variations in the effect of COVID-19 on DTP3 coverage rates, indicating the need for targeted public health strategies to address vaccine hesitancy, logistical barriers, and systemic inequities.
  • Thumbnail Image
    PublicationOpen Access
    A valid and reliable scale to assess cultural sensibility in nursing
    (Elsevier, 2021) Belintxon, Maider; Carvajal, Ana; Pumar Méndez, María Jesús; Rayón Valpuesta, Esperanza; Velasco, Tamara Raquel; Belintxon Martin, Unai; Dogra, Nisha; Vidaurreta, Marta; Bermejo-Martins, Elena; López de Dicastillo Sáinz de Murieta, Olga; Derecho; Zuzenbidea
    Background: cultural sensibility is an important concept linked to the achievement of cultural competence. Health professionals must first improve their cultural sensibility to become culturally competent and to be able to offer competent care to culturally diverse populations. Aim To develop and psychometrically test the Cultural Sensibility Scale for Nursing (CUSNUR), a cultural sensibility scale that can be used in nursing for the achievement of competencies needed to care for culturally diverse populations. Design and methods: the cross-sectional survey was conducted over two stages. The first stage involved the cross-cultural and discipline-specific adaptation of an existing scale addressing this concept in the field of law using the reverse translation method. Second, validation of the scale was carried out from October 2016–June 2017 by studying the psychometric properties of the questionnaire through an analysis of content acceptability and reliability and through exploratory factor analysis (EFA). Results: the questionnaire was designed to be clear, easy to understand, and of adequate length, and experts involved in content validation agreed that the scale meets these criteria. A total of 253 nursing students participated in the validation stage. Four factors were identified from the EFA: (1) patient and health professional behaviours, (2) self-assessments, (3) self-awareness, and (4) cultural influence. Two items were excluded. Factorial saturation is adequate for all factors (>0.30). The Cronbach alpha was measured as 0.75. Conclusions: this study presents the first version of the CUSNUR and demonstrates that the scale is valid and reliable.
  • Thumbnail Image
    PublicationOpen Access
    Has COVID-19 affected DTP3 vaccination in the Americas?
    (MDPI, 2024) Aguinaga Ontoso, Inés; Guillén Aguinaga, Sara; Guillén Aguinaga, Laura; Alas Brun, Rosa María; Aguinaga Ontoso, Enrique; Rayón Valpuesta, Esperanza; Guillén Grima, Francisco; Ciencias de la Salud; Osasun Zientziak
    Background: In the Americas, deaths by diseases avoidable with vaccines are a significant contributor to child mortality. An essential means of reducing this is through broad vaccine coverage. The COVID-19 pandemic has posed a potential disruption to vaccine coverage due to its effects on the healthcare system. Objectives: this study aims to evaluate the impact of the COVID-19 pandemic on DTP3 vaccination coverage in the Americas, investigating trends from 2012 to 2022 to identify significant changes, regional disparities, and the overall effect of the pandemic on progress towards global immunization targets. Methods: This study used the coverage data for the third dose of the diphtheria, tetanus, and pertussis vaccine (DTP3) pulled from UNICEF databases spanning 2012 to 2022. We conducted a Joinpoint regression to identify points of significant trend changes. The annual percentage change (APC) and 95% confidence intervals (95% CIs) were calculated for America and its regions. We also used segmented regression analysis. Using the Chi-square test, we compared DTP3 vaccination coverage for each country between 2019 and 2022. Results: Overall, America saw a decrease in vaccine coverage during this period, with an APC of −1.4 (95% CI −1.8; −1.0). This trend varied across regions. In North America, the decrease was negligible (−0.1% APC). South America showed the steepest decrease, with an APC of −2.5%. Central America also declined, with an APC of −1.3%. Our findings suggest a concerning trend of declining DTP-vaccination rates in the Americas, exacerbated in certain regions, in the wake of the COVID-19 pandemic. The absolute decrease in vaccine coverage in the Americas was −4% between 2019 and 2022, with the most important drop being in Central America (−7%). However, six countries reported increased vaccination rates post-COVID-19, led by Brazil, with a 7% increase. Conversely, twenty-two countries registered a decline in DTP3 vaccine coverage, with the average decrease being −7.37%. This decline poses an important challenge to achieving the WHO’s target of 90% coverage for the third dose of DTP by 2030, as evidenced by the reduction in the number of countries meeting this target from 2019 to 2022. Conclusions: The COVID-19 pandemic has impacted vaccine coverage in America, leading to a decrease, especially across Central America.